MedPath

GeNeuro Australia PTY Ltd

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

Single Ascending Doses Study With GNbAC1 in Healthy Male Volunteers

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
Other: GNbAC1 Placebo
First Posted Date
2018-07-02
Last Posted Date
2020-10-20
Lead Sponsor
GeNeuro Australia PTY Ltd
Target Recruit Count
24
Registration Number
NCT03574428
Locations
🇦🇺

Scientia Clinical Research Ltd, Sydney, New South Wales, Australia

Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years

Phase 2
Completed
Conditions
Diabetes Mellitus Type 1
Interventions
Drug: Placebo
First Posted Date
2017-06-07
Last Posted Date
2020-10-20
Lead Sponsor
GeNeuro Australia PTY Ltd
Target Recruit Count
64
Registration Number
NCT03179423
Locations
🇦🇺

Macquarie University Hospital, Macquarie University, New South Wales, Australia

🇦🇺

AIM Centre, Merewether, New South Wales, Australia

🇦🇺

Northern Sydney Local Health District - Royal North Shore Hospital, St Leonards, New South Wales, Australia

and more 10 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.